DNAJC19P7

Across TCGA pan-cancer cohorts, DNAJC19P7 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DNAJC19P7’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where DNAJC19P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DNAJC19P7 is over-expressed in tumor, although a few such as CHOL and KIRP show the opposite, repressed pattern.

HNSC, BLCA, and LUSC are the cancer types where DNAJC19P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJC19P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.066	.016	5	view →
BLCA	All	All	+0.136	.012	3	view →
LUSC	All	All	+0.072	.006	3	view →
CHOL	All	II,III,IV	−0.260	.005	2	view →
KIRP	Male	All	−0.102	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

DNAJC19P7–HNSC

Open the HNSC breakdown →